One-Stop stroke care could save minutes and lives

NCT ID NCT07052045

Recruiting now Disease control Sponsor: Prof. Dr. Jan Liman Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether doing brain scans and clot-removal procedures in the same room speeds up treatment for severe strokes. About 390 patients with suspected large-vessel blockages will be randomly assigned to either the usual two-room process or a one-room approach. The goal is to see if faster treatment leads to less disability at 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: One-Stop management (flat panel CT imaging and endovascular therapy in the same room)
What this could lead to: If successful, this approach could cut treatment delays, helping more stroke patients recover independence and reducing long-term disability.
What could go wrong: This is a mid-sized trial testing a workflow change, not a new drug. The imaging method may be slightly less accurate for some stroke types, and results may not apply to all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE (AIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hemorrhagic Stroke intracerebral hemorrhage ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE (AIS) HEMORRHAGIC STROKE, INTRACEREBRAL STROKE, ACUTE

Contacts and locations

Locations

Klinik für Neurologie, Universitätsklinik der Paracelsus
RECRUITING

Nuremberg, 90471, Germany
University Hospital Basel
NOT_YET_RECRUITING

Basel, 4031, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.